Mapping lung cancer genes to unlock future treatments

NCT ID NCT02688894

First seen Jun 24, 2026 · Last updated Aug 13, 2026 · Updated 3 times

Summary

This study analyzes tumor tissue from 797 people with relapsed small cell lung cancer to identify genetic subtypes. No drugs are tested here. Instead, the results may help match patients to future targeted therapy trials. Participants must have had prior platinum-based chemotherapy and provide tissue samples.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this screening could identify which genetic subtypes of small cell lung cancer exist, paving the way for more personalized treatment trials.
What could go wrong
This is only a screening study, not a treatment. It does not test any drug, so there is no direct benefit to participants. Results may not lead to effective therapies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE; CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chungbuk University Hospital

    COMPLETED

    Taebuk, South Korea

  • Gachon University Gil Medical Center

    COMPLETED

    Incheon, South Korea

  • Samsung Medical Center

    RECRUITING

    Seoul, 135-710, South Korea

  • Seoul National University Bundang Hospital

    COMPLETED

    Seongnam, South Korea

  • Ulsan University Hospital

    COMPLETED

    Ulsan, South Korea

  • VHS Medical Center

    COMPLETED

    Seoul, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.